We have located links that may give you full text access.
How does exercise, with and without diet, improve pain and function in knee osteoarthritis? A secondary analysis of a randomised controlled trial exploring potential mediators of effects.
Arthritis Care & Research 2023 May 2
OBJECTIVE: Explore mediators of effects of two 6-month telehealth-delivered exercise programs, with and without weight loss diet, on pain and function improvements in knee osteoarthritis.
METHODS: Secondary analysis of 345 participants from a three-arm randomised controlled trial of exercise (Exercise) and exercise plus diet (Diet+Exercise) versus information (Control). Outcomes were changes in pain (11-point Numeric Rating Scale) and function (WOMAC, 0-68) at 12-months. Potential mediators were change at 6 months in i) attitudes towards self-management, ii) fear of movement, iii) arthritis self-efficacy, iv) weight, v) physical activity, and vi) willingness for knee surgery. For Diet+Exercise vs Exercise, only change in weight was evaluated.
RESULTS: Possible mediators of Exercise vs Control included reduced fear of movement (accounting for -1.11 [95% confidence interval: -2.15, -0.07] units improvement in function) and increased arthritis self-efficacy (-0.40 [-0.75, -0.06] reduction in pain, -1.66 [-3.04, -0.28] improvement in function). Diet+Exercise vs Control mediators included reduced fear of movement (-1.13 [-2.17, -0.08] improvement in function), increased arthritis self-efficacy (-0.77 [-1.26, -0.28] reduction in pain, -5.15 [-7.34, -2.96] improvement in function), and weight loss (-1.20 [-1.73, -0.68] reduction in pain, -5.79 [-7.96, -3.63] improvement in function). Weight loss mediated Diet+Exercise vs Exercise (-0.89 [-1.31, -0.47] reduction in pain, -4.02 [-5.77, -2.26] improvement in function).
CONCLUSION: Increased arthritis self-efficacy, reduced fear of movement, and weight loss may partially mediate telehealth-delivered exercise program effects, with and without diet, on pain and/or function in knee osteoarthritis. Weight loss may partially mediate the effect of diet plus exercise, compared to exercise alone. This article is protected by copyright. All rights reserved.
METHODS: Secondary analysis of 345 participants from a three-arm randomised controlled trial of exercise (Exercise) and exercise plus diet (Diet+Exercise) versus information (Control). Outcomes were changes in pain (11-point Numeric Rating Scale) and function (WOMAC, 0-68) at 12-months. Potential mediators were change at 6 months in i) attitudes towards self-management, ii) fear of movement, iii) arthritis self-efficacy, iv) weight, v) physical activity, and vi) willingness for knee surgery. For Diet+Exercise vs Exercise, only change in weight was evaluated.
RESULTS: Possible mediators of Exercise vs Control included reduced fear of movement (accounting for -1.11 [95% confidence interval: -2.15, -0.07] units improvement in function) and increased arthritis self-efficacy (-0.40 [-0.75, -0.06] reduction in pain, -1.66 [-3.04, -0.28] improvement in function). Diet+Exercise vs Control mediators included reduced fear of movement (-1.13 [-2.17, -0.08] improvement in function), increased arthritis self-efficacy (-0.77 [-1.26, -0.28] reduction in pain, -5.15 [-7.34, -2.96] improvement in function), and weight loss (-1.20 [-1.73, -0.68] reduction in pain, -5.79 [-7.96, -3.63] improvement in function). Weight loss mediated Diet+Exercise vs Exercise (-0.89 [-1.31, -0.47] reduction in pain, -4.02 [-5.77, -2.26] improvement in function).
CONCLUSION: Increased arthritis self-efficacy, reduced fear of movement, and weight loss may partially mediate telehealth-delivered exercise program effects, with and without diet, on pain and/or function in knee osteoarthritis. Weight loss may partially mediate the effect of diet plus exercise, compared to exercise alone. This article is protected by copyright. All rights reserved.
Full text links
Related Resources
Trending Papers
Drug-Induced Myocardial Infarction: A Review of Pharmacological Triggers and Pathophysiological Mechanisms.Journal of Cardiovascular Development and Disease 2024 December 18
Treatment strategies to reduce cardiovascular risk in persons with chronic kidney disease and Type 2 diabetes.Journal of Internal Medicine 2024 December 31
Guidelines for administering gadolinium-based contrast agents to patients with renal dysfunction (Version 3: Revised May 20th, 2024).Clinical and Experimental Nephrology 2025 January 3
The PRECISE trial: How should patients with chest pain be tested?Cleveland Clinic Journal of Medicine 2024 November 1
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2025 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app